Abcombi Biosciences

    OverviewSuggest Edit

    Abcombi Biosciences (ABI) is a preclinical-stage biotechnology company that focuses on the vaccine and therapeutic development area. It provides a biofilm model that mimics the natural progression of disease for colonizing bacteria such Streptococcus pneumoniae and Staphylococcus aureus. In addition, the company specializes in bioinformatics, polysaccharide conjugate vaccine manufacturing, and RNA-based therapy for treating influenza infections.
    TypePrivate
    Founded2015
    Websiteabcombibio.com

    Latest Updates

    Employees (est.) (Feb 2021)3
    Cybersecurity ratingAMore

    Abcombi Biosciences Financials and Metrics

    Summary Metrics

    Founding Date

    2015

    Abcombi Biosciences Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    91/100

    SecurityScorecard logo

    Abcombi Biosciences Online and Social Media Presence

    Embed Graph

    Abcombi Biosciences Frequently Asked Questions

    • When was Abcombi Biosciences founded?

      Abcombi Biosciences was founded in 2015.

    • How many employees does Abcombi Biosciences have?

      Abcombi Biosciences has 3 employees.

    • Who are Abcombi Biosciences competitors?

      Competitors of Abcombi Biosciences include Triumvira, Tikomed and Sanofi.